
Akm E. Ullah
Examiner (ID: 10221, Phone: (571)272-2361 , Office: P/2874 )
| Most Active Art Unit | 2874 |
| Art Unit(s) | 2874, 2606, 2501, 1734, 2899, 3621, 2838 |
| Total Applications | 3400 |
| Issued Applications | 3065 |
| Pending Applications | 95 |
| Abandoned Applications | 245 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5085331
[patent_doc_number] => 20070275382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'Biomarkers for the Efficacy of Somatostatin Analogue Treatment'
[patent_app_type] => utility
[patent_app_number] => 10/580778
[patent_app_country] => US
[patent_app_date] => 2004-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10822
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20070275382.pdf
[firstpage_image] =>[orig_patent_app_number] => 10580778
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/580778 | Biomarkers for the Efficacy of Somatostatin Analogue Treatment | Nov 23, 2004 | Abandoned |
Array
(
[id] => 6958368
[patent_doc_number] => 20050214738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Conditional allele system'
[patent_app_type] => utility
[patent_app_number] => 10/992304
[patent_app_country] => US
[patent_app_date] => 2004-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 25406
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20050214738.pdf
[firstpage_image] =>[orig_patent_app_number] => 10992304
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/992304 | Conditional allele system | Nov 16, 2004 | Abandoned |
Array
(
[id] => 7103945
[patent_doc_number] => 20050106671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Expression vector, host cell and method for producing fusion proteins'
[patent_app_type] => utility
[patent_app_number] => 10/990718
[patent_app_country] => US
[patent_app_date] => 2004-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4616
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20050106671.pdf
[firstpage_image] =>[orig_patent_app_number] => 10990718
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/990718 | Expression vector, host cell and method for producing fusion proteins | Nov 16, 2004 | Abandoned |
Array
(
[id] => 4921924
[patent_doc_number] => 20080070239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'Detection of neureopeptides associated with pelvic pain disorders and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/577395
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9590
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20080070239.pdf
[firstpage_image] =>[orig_patent_app_number] => 10577395
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/577395 | Detection of neureopeptides associated with pelvic pain disorders and uses thereof | Oct 28, 2004 | Abandoned |
Array
(
[id] => 6938547
[patent_doc_number] => 20050112110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Promoters exhibiting endothelial cell specificity and methods of using same'
[patent_app_type] => utility
[patent_app_number] => 10/975619
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 20342
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112110.pdf
[firstpage_image] =>[orig_patent_app_number] => 10975619
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/975619 | Promoters exhibiting endothelial cell specificity and methods of using same | Oct 28, 2004 | Issued |
Array
(
[id] => 7127334
[patent_doc_number] => 20050059078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Vectors and methods for the mutagenesis of mammalian genes'
[patent_app_type] => utility
[patent_app_number] => 10/974603
[patent_app_country] => US
[patent_app_date] => 2004-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8775
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059078.pdf
[firstpage_image] =>[orig_patent_app_number] => 10974603
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/974603 | Vectors and methods for the mutagenesis of mammalian genes | Oct 26, 2004 | Issued |
Array
(
[id] => 8363860
[patent_doc_number] => 08252917
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-28
[patent_title] => 'High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of MAR sequences'
[patent_app_type] => utility
[patent_app_number] => 10/595495
[patent_app_country] => US
[patent_app_date] => 2004-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 19
[patent_no_of_words] => 21059
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10595495
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/595495 | High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of MAR sequences | Oct 21, 2004 | Issued |
Array
(
[id] => 5716311
[patent_doc_number] => 20060079674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Contraceptive targets'
[patent_app_type] => utility
[patent_app_number] => 10/965103
[patent_app_country] => US
[patent_app_date] => 2004-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 44906
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20060079674.pdf
[firstpage_image] =>[orig_patent_app_number] => 10965103
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/965103 | Contraceptive targets | Oct 13, 2004 | Abandoned |
Array
(
[id] => 7167916
[patent_doc_number] => 20050086708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Animal models of retinal tumorigenesis'
[patent_app_type] => utility
[patent_app_number] => 10/962832
[patent_app_country] => US
[patent_app_date] => 2004-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15532
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20050086708.pdf
[firstpage_image] =>[orig_patent_app_number] => 10962832
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/962832 | Animal models of retinal tumorigenesis | Oct 11, 2004 | Abandoned |
| 10/951906 | Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression | Sep 28, 2004 | Abandoned |
Array
(
[id] => 4839800
[patent_doc_number] => 20080280286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-13
[patent_title] => 'Compositions and Methods for Gene Expression'
[patent_app_type] => utility
[patent_app_number] => 10/574333
[patent_app_country] => US
[patent_app_date] => 2004-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 34820
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20080280286.pdf
[firstpage_image] =>[orig_patent_app_number] => 10574333
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/574333 | Compositions and methods for gene expression | Sep 28, 2004 | Issued |
| 10/951907 | Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression | Sep 28, 2004 | Abandoned |
Array
(
[id] => 5016198
[patent_doc_number] => 20070259407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => 'Enzyme for an in Vivo and in Vitro Utilisation of Carbohydrates'
[patent_app_type] => utility
[patent_app_number] => 10/571597
[patent_app_country] => US
[patent_app_date] => 2004-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7936
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20070259407.pdf
[firstpage_image] =>[orig_patent_app_number] => 10571597
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/571597 | Enzyme for an in Vivo and in Vitro Utilisation of Carbohydrates | Sep 12, 2004 | Abandoned |
Array
(
[id] => 5807664
[patent_doc_number] => 20060094018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Discovery and a method for the early detection of pancreatic cancer and other disease conditions'
[patent_app_type] => utility
[patent_app_number] => 10/938696
[patent_app_country] => US
[patent_app_date] => 2004-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3393
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094018.pdf
[firstpage_image] =>[orig_patent_app_number] => 10938696
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/938696 | Discovery and a method for the early detection of pancreatic cancer and other disease conditions | Sep 10, 2004 | Abandoned |
Array
(
[id] => 8336003
[patent_doc_number] => 20120202710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-09
[patent_title] => 'Methods and compositions for generation of germline human antibody genes'
[patent_app_type] => utility
[patent_app_number] => 10/571574
[patent_app_country] => US
[patent_app_date] => 2004-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14081
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10571574
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/571574 | Methods and compositions for generation of germline human antibody genes | Sep 8, 2004 | Abandoned |
Array
(
[id] => 5912298
[patent_doc_number] => 20060127360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Multi-antigen vectors of melanoma'
[patent_app_type] => utility
[patent_app_number] => 10/933874
[patent_app_country] => US
[patent_app_date] => 2004-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 12512
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20060127360.pdf
[firstpage_image] =>[orig_patent_app_number] => 10933874
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/933874 | Multi-antigen vectors of melanoma | Sep 2, 2004 | Issued |
Array
(
[id] => 7263189
[patent_doc_number] => 20040261139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Androgen receptor knock-out transgenic animals'
[patent_app_type] => new
[patent_app_number] => 10/484950
[patent_app_country] => US
[patent_app_date] => 2004-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 33561
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20040261139.pdf
[firstpage_image] =>[orig_patent_app_number] => 10484950
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/484950 | Androgen receptor knock-out transgenic animals | Aug 15, 2004 | Abandoned |
Array
(
[id] => 7347864
[patent_doc_number] => 20040248140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Nucleotidic sequences having activity of controlling translation efficiency and utilization thereof'
[patent_app_type] => new
[patent_app_number] => 10/500346
[patent_app_country] => US
[patent_app_date] => 2004-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10887
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248140.pdf
[firstpage_image] =>[orig_patent_app_number] => 10500346
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/500346 | Nucleotidic sequences having activity of controlling translation efficiency and utilization thereof | Jul 28, 2004 | Abandoned |
Array
(
[id] => 7060560
[patent_doc_number] => 20050002920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Antigen presenting cells, method for their preparation and their use for cancer vaccines'
[patent_app_type] => utility
[patent_app_number] => 10/898187
[patent_app_country] => US
[patent_app_date] => 2004-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9963
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20050002920.pdf
[firstpage_image] =>[orig_patent_app_number] => 10898187
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/898187 | Antigen presenting cells, method for their preparation and their use for cancer vaccines | Jul 25, 2004 | Abandoned |
Array
(
[id] => 7328328
[patent_doc_number] => 20040253631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Recombinational cloning using nucleic acids having recombination sites'
[patent_app_type] => new
[patent_app_number] => 10/893235
[patent_app_country] => US
[patent_app_date] => 2004-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 58
[patent_no_of_words] => 29689
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20040253631.pdf
[firstpage_image] =>[orig_patent_app_number] => 10893235
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/893235 | Recombinational cloning using nucleic acids having recombination sites | Jul 18, 2004 | Issued |